Jakob Dupont
Director/Board Member chez IMUGENE LIMITED
Fortune : 372 964 $ au 31/03/2024
Profil
Jakob Dupont is currently serving as a Non-Executive Director at Imugene Ltd., Director at Apexigen America, Inc., Independent Director at Pyxis Oncology, Inc., Executive Partner at Sofinnova Investments, Inc., and Advisor at Ambrx, Inc. In the past, he worked as Global Director-Medical at Genentech, Inc., Chief Medical Officer & Senior Vice President at OncoMed Pharmaceuticals, Inc., VP & Global Head-Gynecologic Cancer Development at Genentech, Inc., and Chief Medical Officer at Gossamer Bio, Inc. He also served as Faculty Member at Memorial Sloan Kettering Cancer Center.
Dr. Dupont holds a graduate degree from New York University, an undergraduate degree from Vassar College, and a doctorate from Weill Cornell Medical College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/03/2023 | 290 794 ( 0,23% ) | 201 811 $ | 31/03/2024 | |
PYXIS ONCOLOGY, INC.
0,07% | 26/03/2024 | 38 741 ( 0,07% ) | 165 037 $ | 31/03/2024 |
IMUGENE LTD
0,00% | 12/01/2024 | 89 286 ( 0,00% ) | 6 116 $ | 31/03/2024 |
Postes actifs de Jakob Dupont
| Sociétés | Poste | Début |
|---|---|---|
| IMUGENE LIMITED | Director/Board Member | 07/09/2022 |
| AMBRX INC | Consultant / Advisor | 01/03/2021 |
| PYXIS ONCOLOGY, INC. | Director/Board Member | 23/08/2023 |
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Director/Board Member | 19/08/2020 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Private Equity Investor | 01/05/2023 |
Anciens postes connus de Jakob Dupont
| Sociétés | Poste | Fin |
|---|---|---|
| APEXIGEN, INC. | Director/Board Member | 23/08/2023 |
| ATARA BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 12/05/2023 |
| GOSSAMER BIO, INC. | Chief Tech/Sci/R&D Officer | 01/05/2020 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/12/2018 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Jakob Dupont
| New York University | Graduate Degree |
| Vassar College | Undergraduate Degree |
| Weill Cornell Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| IMUGENE LIMITED | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| PYXIS ONCOLOGY, INC. | Health Technology |
| APEXIGEN, INC. | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Finance |
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Health Services |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Health Technology |
